HIV Prevention: A Guide to PrEP and PEP

Listen in as we explore the latest pharmacologic strategies for HIV prevention—before and after exposure. Our expert panel breaks down key considerations for PrEP and PEP, including indications, drug selection, dosing, and monitoring.

Special guests:

• Caitlin Prather, PharmD, BCACP, AAHIVP
  • Clinical Pharmacy Specialist, Ambulatory Care
  • Inova Health System
• Michael A. Deaney, PharmD, AAHIVP
  • Infectious Diseases Clinical Pharmacist
  • Children's Hospital Colorado

You’ll also hear practical advice from TRC’s Editorial Advisory Board member:

• Andrea Darby-Stewart, MD
  • Associate Director, Honor Health Family Medicine Residency Program
  • Clinical Professor of Family, Community & Occupational Medicine
  • The University of Arizona College of Medicine - Phoenix

For the purposes of disclosure, Dr. Prather reports a relevant financial relationship [HIV PrEP] with Viiv Healthcare (speakers bureau).

The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.

This podcast is an excerpt from one of TRC’s monthly live CE webinars, the full webinar originally aired in June 2025.

TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.

Claim Credit

The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: 

• Checklist: HIV Pre-Exposure Prophylaxis (PrEP)
• Checklist: HIV Postexposure Prophylaxis (PEP) Checklist

Send a text

Email us: [email protected].

The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

Learn more about our product offerings at trchealthcare.com.